New Vaccine Promises Cure For Two Deadly Cancers In Clinical Trial
A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal cancer is showing promising results Researchers in Nature Medicine reported that the vaccine, called ELI-002 2P, offers fresh hope for individuals affected by pancreatic and colorectal cancer, following promising outcomes in a recent clinical trial. Pancreatic…